Boston, MA | April 8, 2021
BOSTON — April 8, 2021 — Scorpion Therapeutics, Inc., a next-generation precision oncology company, today announced the appointment of Guy Padbury, Ph.D. as Chief Development Officer....
February 25, 2021
– Board Appoints Adam Friedman, M.D., Ph.D., as Interim CEO – Scorpion Therapeutics announced that Adam Friedman, M.D., Ph.D., has been appointed Chief Executive Officer on an interim basis. The Board of Directors is currently evaluating...
Fierce Biotech | January 12, 2021
Less than three months after breaking cover with an impressive $102 million series A, Scorpion has whipped up another major funding round, nabbing $162 million for its next-gen cancer drugs.
Boston Globe | January 12, 2021
Just over two months after announcing its debut with $108 million in funding, Boston startup Scorpion Therapeutics said Thursday it has raised an even larger amount of venture capital.
Endpoints News | January 12, 2021
Whatever investors have peeped about Gary Glick and Keith Flaherty’s game plan to bring about Precision Oncology 2.0, it’s good enough for a $162 million infusion into Scorpion Therapeutics just weeks after its $108 million Series A.
January 7, 2021
— Proceeds support advancement of Precision Oncology 2.0 drug-hunting engine and first wave of therapeutic candidates — — Company management to present at 39th Annual J.P....
Fierce Biotech | October 26, 2020
When Gary Glick, Ph.D., left the CEO post at IFM Therapeutics, he didn’t know what was next. But he soon found himself on a plane with Loxo Oncology co-founder Keith Flaherty, and they got to talking about how they could “expand the boundaries of targeted oncology.”
Boston Globe | October 26, 2020
Gary Glick is chief executive of Scorpion Therapeutics. Courtesy of Scorpion Therapeutics. Scorpion Therapeutics is the latest biotech to debut in Boston, with $108 million in venture capital and a roster of local industry veterans.
Endpoints News | October 26, 2020
Just weeks before the pandemic hit the states, Gary Glick and Keith Flaherty had a chance to spend 12 hours together, talking craft and trade on...